News

ISTAT. New collapse in January in sales and orders in the pharmaceutical industry

In January, industry turnover is estimated to increase by 3.1% in quarterly terms. In the average of the last three months, out of the previous three, the overall index still shows a drop of 1.8%. Orders also recorded a cyclical growth of 1.8% compared to the previous month, while in the average of the last three months there was also a reduction compared to the previous three months (-2.1%).

The cyclical increase in turnover regards both the domestic market (+2.3%) and, to a more accentuated extent, the foreign market (+4.5%). The growth in orders is the synthesis of a decline in orders from the domestic market (-1.1%) and a marked increase in those from abroad (+6.0%).

All the main groupings of industries report a positive cyclical change: +4.6% for energy, +4.1% for capital goods, +2.5% for intermediate goods and +2.4% for consumer goods.

Corrected for calendar effects (there were 22 working days, as in January 2018), total turnover grew in trend terms by 0.6%, with a decrease of 0.1% on the domestic market and an increase of 1.9% on the foreign one.

With reference to the manufacturing sector the sales adjusted for calendar effects, it recorded the highest year-on-year growth in the machinery and equipment sector (+8.8%) and the the most significant decrease in the pharmaceutical industry (-13.8%).

The raw index of orders shows a trend decline of 1.2%, deriving from decreases both for the domestic market (-1.9%) and, to a lesser extent, for the foreign market (-0.2%). The greatest growth is recorded for the textile industries (+5.4%), while the most marked decrease was seen in the pharmaceutical industry (-5.1%).

ISTAT press release - 15 March 2019

Full text and methodological note


Note: What is happening to pharmaceuticals is not easily understood. According to some observers, it is a phenomenon linked to the seasonality of demand; according to others, companies are engaged in the digital transformation linked to the serialization of products required by a European directive that entered into force last month. This can also be seen in the raw index of orders (which generally shows a downward trend of 1.2%, deriving from decreases both for the domestic market equal to -1.9% and, to a lesser extent, for the foreign market equal to -0.2%): also here the most marked decrease is found in the pharmaceutical industry (-5.1%)

Related news: Pharmaceutical. Menarini, turnover (+1.6%) and employees grow

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco